Rossella Galli

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications

Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression.

Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression.

Journal: Cancer research
Published: June 25, 2025

Non-invasive identification of mesenchymal glioblastoma using quantitative radiomic features from advanced diffusion MRI: a preclinical-to-clinical transfer learning strategy.

Non-invasive identification of mesenchymal glioblastoma using quantitative radiomic features from advanced diffusion MRI: a preclinical-to-clinical transfer learning strategy.

Journal: European radiology experimental
Published: June 18, 2025

The NeuroSphere Assay Applied to Neural Stem Cells and Cancer Stem Cells.

The NeuroSphere Assay Applied to Neural Stem Cells and Cancer Stem Cells.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 31, 2025

A blueprint for local and distal invasion programs in glioblastoma.

A blueprint for local and distal invasion programs in glioblastoma.

Journal: Nature communications
Published: November 01, 2024

Concurrent RB1 and P53 pathway disruption predisposes to the development of a primitive neuronal component in high-grade gliomas depending on MYC-driven EBF3 transcription.

Concurrent RB1 and P53 pathway disruption predisposes to the development of a primitive neuronal component in high-grade gliomas depending on MYC-driven EBF3 transcription.

Journal: Acta neuropathologica
Published: October 21, 2024

Modulating voltage-gated sodium channels to enhance differentiation and sensitize glioblastoma cells to chemotherapy.

Modulating voltage-gated sodium channels to enhance differentiation and sensitize glioblastoma cells to chemotherapy.

Journal: Cell communication and signaling : CCS
Published: April 05, 2024

Acid-sensing ion channel 3 is a new potential therapeutic target for the control of glioblastoma cancer stem cells growth.

Acid-sensing ion channel 3 is a new potential therapeutic target for the control of glioblastoma cancer stem cells growth.

Journal: Scientific reports
Published: February 02, 2024

Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumors.

Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumors.

Journal: Journal of neuro-oncology
Published: January 31, 2023

Aberrant L-Fucose Accumulation and Increased Core Fucosylation Are Metabolic Liabilities in Mesenchymal Glioblastoma.

Aberrant L-Fucose Accumulation and Increased Core Fucosylation Are Metabolic Liabilities in Mesenchymal Glioblastoma.

Journal: Cancer research
Published: February 25, 2022

CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function.

CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function.

Journal: Science translational medicine
Published: February 09, 2022

mTORC1 promotes malignant large cell/anaplastic histology and is a targetable vulnerability in SHH-TP53 mutant medulloblastoma.

mTORC1 promotes malignant large cell/anaplastic histology and is a targetable vulnerability in SHH-TP53 mutant medulloblastoma.

Journal: JCI insight
Published: July 22, 2021

Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma.

Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma.

Journal: Frontiers in oncology
Published: February 04, 2021
Showing 1-12 of 39

Last Updated: 09/26/2026